I Take Uterine Cancer Seriously and You Should Too! Even Though the Risk Is Small | Felice Gersh, MD

Why It Matters

Early investigation of abnormal postmenopausal bleeding can catch endometrial cancer at a treatable stage, reducing mortality and healthcare costs.

Key Takeaways

• Uterine cancer primarily affects postmenopausal women over 40.
• Over 95% of cases occur in women not using hormone therapy.
• Median diagnosis age is mid‑60s, with risk extending into 70s‑80s.
• Unexpected bleeding in older women mandates immediate endometrial cancer rule‑out.
• Adequate progesterone lowers but does not eliminate cancer risk.

Summary

Dr. Felice Gersh, MD, uses this brief video to highlight uterine (endometrial) cancer as a disease that overwhelmingly targets postmenopausal women, especially those over 40. She notes that more than 95% of cases arise in women who are not on any form of hormone replacement therapy, underscoring that the condition is largely independent of exogenous hormones.

The data points she cites are stark: the median age at diagnosis falls in the mid‑60s, with a substantial tail of cases extending into the 70s and 80s. While a standard hormonal regimen that includes sufficient progesterone can modestly reduce risk, it does not make cancer impossible. Consequently, any unexpected or abnormal uterine bleeding in an older woman—particularly one not on hormones—must trigger an immediate work‑up to rule out adenocarcinoma of the endometrium.

Gersh repeatedly emphasizes the mantra “rule out, rule out, rule out,” illustrating the clinical urgency. She also references the rarity of the disease in younger, pre‑menopausal women, reinforcing that age and menopausal status are the dominant risk factors.

The implication for clinicians and patients alike is clear: vigilance for abnormal bleeding should be a routine part of postmenopausal care, and prompt diagnostic evaluation can dramatically improve outcomes. Early detection remains the most effective tool against a cancer that, while statistically uncommon, carries significant mortality when caught late.

Original Description

Uterine cancer is overwhelmingly a postmenopausal diagnosis. The vast majority of cases occur in women not taking hormone therapy at all. More than 95% happen after age 40, with most diagnoses after 55. The peak? The mid-sixties. And yes, it can occur in women in their seventies and eighties as well.

Even women on a standard hormone regimen with adequate progesterone can develop endometrial adenocarcinoma. It’s uncommon, but uncommon does not mean impossible.

So if a postmenopausal woman has unexpected bleeding — especially if she is not on hormones — it is always rule out, rule out, rule out endometrial cancer.

Learn more, watch my full talk,

How progesterone protects your uterus from cancer.

Implications for menopause HRT

https://youtu.be/-JvwE8fl16Q

#uterinecancer #adenocarcinoma #postmenopausalbleeding #postmenopausalhealth #cancerprevention